| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |